219
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Identifying novel small molecule antagonists for mLST8 protein using computational approaches

, , , , &
Pages 1-11 | Received 03 Mar 2017, Accepted 26 Sep 2017, Published online: 17 Oct 2017

References

  • Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122:3589–3594.
  • Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol. 2011;23:744–755.
  • Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18:1926–1945.
  • Kim D-H, Sarbassov DD, Ali SM, et al. GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell. 2003;11:895–904.
  • Yang H, Rudge DG, Koos JD, et al. mTOR kinase structure, mechanism and regulation. Nature. 2013;497:217–223.
  • Xu C, Min J. Structure and function of WD40 domain proteins. Protein Cell. 2011;2:202–214.
  • Smith TF, Gaitatzes C, Saxena K, et al. The WD repeat: a common architecture for diverse functions. Trends Biochem Sci. 1999;24:181–185.
  • Zou X-D, Hu X-J, Ma J, et al. Genome-wide analysis of WD40 protein family in human. Sci Rep. 2016;6:39262.
  • Baretić D, Williams RL. The structural basis for mTOR function. Semin Cell Dev Biol. 2014;36:91–101.
  • Kakumoto K, Ikeda J, Okada M, et al. mLST8 promotes mTOR-mediated tumor progression. PLoS One. 2015;10:e0119015.
  • Armengol G, Rojo F, Castellví J, et al. 4E-binding protein 1: a key molecular “funnel factor” in human cancer with clinical implications. Cancer Res. 2007;67:7551–7555.
  • Liu P, Gan W, Inuzuka H, et al. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol. 2013;15:1340–1350.
  • Orlicky S, Tang X, Neduva V, et al. An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase. Nat Biotechnol. 2010;28:733–737.
  • Irwin JJ, Shoichet BK. ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45:177–182.
  • Irwin JJ, Sterling T, Mysinger MM, et al. ZINC: a free tool to discover chemistry for biology. J Chem Inf Model. 2012;52:1757–1768.
  • Lešnik S, Stular T, Brus B, Knez D, et al. LiSiCA: a software for ligand-based virtual screening and its application for the discovery of butyrylcholinesterase inhibitors. J Chem Inf Model. 2015;55:1521–1528.
  • Binkowski TA, Naghibzadeh S, Liang J. CASTp: computed atlas of surface topography of proteins. Nucleic Acids Res. 2003;31:3352–3355.
  • Dundas J, Ouyang Z, Tseng J, et al. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res. 2006;34(2):W116–W1W8.
  • Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47:1739–1749.
  • Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006;49:6177–6196.
  • Accelyrs Software Inc. Discovery studio modeling environment R, San Diego (CA): Accelyrs Sodtware Inc; 2011.
  • Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51:2778–2786.
  • Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera: a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605–1612.
  • Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10:449–461.
  • Norinder U, Bergström CA. Prediction of ADMET properties. ChemMedChem. 2006;1:920–937.
  • Van De Waterbeemd H, Gifford E. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov. 2003;2:192–204.
  • Jatana N, Sharma A, Latha N. Pharmacophore modeling and virtual screening studies to design potential COMT inhibitors as new leads. J Mol Graph Model. 2013;39:145–164.
  • Pandey RK, Narula A, Naskar M, et al. Exploring dual inhibitory role of febrifugine analogues against plasmodium utilizing structure-based virtual screening and molecular dynamic simulation. J Biomol Struct Dyn. 2017;35:791–804.
  • Abraham MJ, Lindahl E, Hess B. The GROMACS development team. Gromacs User Manual version 5.1.2. Groningen: University of Groningen; 2016.
  • SchuÈttelkopf AW, Van Aalten DM. PRODRG: a tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004;60:1355–1363.
  • Maisuradze GG, Leitner DM. Free energy landscape of a biomolecule in dihedral principal component space: sampling convergence and correspondence between structures and minima. Proteins. 2007;67:569–578.
  • Muthu K, Panneerselvam M, Topno NS, et al. Structural perspective of ARHI mediated inhibition of STAT3 signaling: an insight into the inactive to active transition of ARHI and its interaction with STAT3 and importinβ. Cell Signal. 2015;27:739–755.
  • Wang Y, Hu X-J, Zou X-D, et al. WDSPdb: a database for WD40-repeat proteins. Nucleic Acids Res. 2014;43:D339–DD44.
  • Wu X-H, Wang Y, Zhuo Z, et al. Identifying the hotspots on the top faces of WD40-repeat proteins from their primary sequences by β-bulges and DHSW tetrads. PLoS One. 2012;7:e43005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.